Rare diseases
Investigational molecules
Locations
957 Ferndale Drive, 92881-8751, United States
Research activity is centered on non-small cell lung cancer, with attention to molecularly defined disease and treatment needs in advanced lung cancer.
The sponsor’s clinical interest is directed toward patients with EGFR-mutated disease and other biologically distinct forms of non-small cell lung cancer.
Wayshine Biopharm Inc. runs clinical trials in conditions such as Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
